Feb 09, 2022 / 01:00PM GMT
Operator
Welcome to the AVROBIO WORLDSymposium 2022 Cystinosis Update Call. My name is John, I'll be your operator for today's call. (Operator Instructions) Please note the conference is being recorded.
And I will now turn the call over to Geoff MacKay, Chief Executive Officer of AVROBIO. You may begin.
Geoff MacKay - AVROBIO, Inc. - Co- Founder, President, CEO & Director
Thank you for tuning into our AVROBIO investor update on our investigational gene therapy program in cystinosis. We'll review new data being presented later today by our collaborator, Professor Stephanie Cherqui and her team at UCSD at this week's world symposium in San Diego. The press release announcing these updates can be found on the investor relations section of our website.
Before we begin, I'll review our safe harbor statement. Today's discussion contains statements that are forward looking under the Private Securities Litigation Reform Act of 1995, including statements based on our current plans, expectations and beliefs. Such statements are subject to a number of risks
AVROBIO Inc Cystinosis Update Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
